期刊
ONCOIMMUNOLOGY
卷 2, 期 11, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.26967
关键词
MDSC; listeria; cancer vaccine; tumor microenvironment; targeted therapy
资金
- NIA NIH HHS [R01 AG023096, T32 AG023475] Funding Source: Medline
While conventional anticancer therapies, including surgical resection, radiotherapy, and/or chemotherapy, are relatively efficient at eliminating primary tumors, these treatment modalities are largely ineffective against metastases. At least in part, this reflects the rather inefficient delivery of conventional anticancer agents to metastatic lesions. We have recently demonstrated that myeloid-derived suppressor cells (MDSCs) can be used as cellular missiles to selectively deliver a radioisotope-coupled attenuated variant of Listeria monocytogenes to both primary and metastatic neoplastic lesions in mice with pancreatic cancer. This novel immunotherapeutic intervention robustly inhibited tumor growth while promoting a dramatic decrease in the number of metastases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据